Company Directory

1 | 2 | 3 | 4 | 5 ... »

Adaltis Developpement inc.

2004 - 2008

Adaltis is an international in-vitro diagnostic company having its headquarters in Montreal, Canada. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses. Return to the parent company in January 2008.

10900, Hamon Street Montréal (Québec) H3M 3A2
Phone : (514) 335-9922  |  Fax : (514) 335-991919
Website :

Anatis Bioprotection inc.

2009 -

Anatis Bioprotection specializes in production and sale of biological control agents (beneficial insects and microbial products) against insect pests as an alternative to chemical pesticides. We have experience in production of: 1) substrates for beneficial insects (e.g. eggs of Ephestia kuehniella moth) 2) several entomophagous insect species, predators and parasites 3) various microbiological formulations against important insect pests.

With a strong experienced team and innovation technology unique to insect production to its credit, Anatis Bioprotection is currently the only company of its kind in Québec.

The Anatis team has developed a series of microbiological products based on entomopathogenic fungi against the most important pests in agriculture: the Colorado potato beetle and the Lygus bug.

230, Bernard-Belleau

Laval (Quebec) H7V 4A9

Téléphone : (514) 577-0817

Télécopieur : (514) 485-0323

Website :

AngioChem inc.

2004 - 2007

AngioChem has the potential to become a leader in the field of Central Nervous System (CNS) disorders following the development of a technology platform allowing the delivery of drugs to the brain without breaking the integrity of the Blood-Brain Barrier. Short term, the company is developing innovative drugs to treat brain tumours but it is already anticipating addressing some numerous unmet medical needs for other diseases of the CNS.

141, President Kennedy Avenue Suite SB-5210 Montréal (Québec) H2X 3Y7
Phone : (514) 788-7800  |  Fax : (514) 788-7801
Website :

Aurelium BioPharma inc.

1998 - 2003

An emerging company that uses functional proteomics to identify new targets for the treatment of multi-drug resistance in cancer.

Ended its operations in 2010.

Bio-K + Pharma inc.

2009 -

Located in the Scientific Park in Laval, Bio-K+ Pharma® is a division of Bio-K+ International Inc., a company specialised in the production, sales and distribution of probiotic products. Bio-K+ Pharma® is dedicated to the screening of intestinal bacteria to develop: 1) new products that will prevent or treat various bacterial or viral infections by the modulation of the immune system; 2) compounds that will relieve the symptoms of chronic inflammatory bowel diseases such as Crohn’s and ulcerative colitis; 3) bacterial molecules that could be used as adjuvants during anticancer chemotherapy. Bio-K+ Pharma® also conducted clinical trials on the finished product that are available on the market in order to validate in vitro experimental results.

500, Cartier West Blvd., Suite 218 Laval (Québec) H7V 5B7
Phone : (450) 781-3961  |  Fax : (450) 781-3962
Website :

1 | 2 | 3 | 4 | 5 ... »


« The top-tier technical and organizational support of CQIB has contributed, to a large extent, to the set up and the growth of the company.. »

- Mark Kaufmann, President Allostera Pharma inc.




Gouvernement du Québec Développement économique Canada pour les régions du Québec

Partners and Sponsors

  • Biotech City
  • I4B
  • Univalor
  • Laval Technopole
  • Ville de Laval
  • RBC Financial Group
  • Praxair
  • Nova Vision
  • INRS University
  • Fisher Scientific Canada
  • CLD de Laval